IMR Press / CEOG / Volume 25 / Issue 4 / pii/1998039

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Suppressed apoptotic susceptibility in human endometrial epithelial cells pretreated with hepatocyte growth factor

Show Less
1 Department of Obstyetrics & Gynecology, Osaka City University Medical School, Osaka (Japan)
Clin. Exp. Obstet. Gynecol. 1998, 25(4), 125–128;
Published: 10 December 1998
Abstract

Hepatocyte growth factor (HGF) and its receptor are strongly expressed perimenstrually in human endometrial epithelium, but their functions remain unknown. In this study the effects of HGF on Fas-mediated apoptosis in the human endometrial epithelial cell line HHUA were investigated. It was found that HGF inhibited Fas-mediated growth suppression and DNA fragmentation in the cells without any increase in Fas antigen expression on the cells. This results suggests that HGF inhibits Fas-mediated apopto­tic signals in the endometrium, and possibly plays a role in reshaping the endometrium during menstruation.

Keywords
HGF
C-met
Endometrium
Apoptosis
Menstruation
Share
Back to top